Faculty headshot of Thelma Escobar, PhD

Grant for Escobar Lab Funds AML Research

July 13, 2022 | Categories: Award, Core Faculty, Research | Tagged: , , , , ,

Thelma Escobar, PhD is collaborating with the Doulatov Lab and the Stem Cell Core to study how mutations in the gene NPM1 drive AML onset. Read More

Francisco Saavedra Cantillana is a Pew Latin American Fellow

June 30, 2022 | Categories: Award | Tagged: , ,

Francisco Saavedra Cantillana PhD, a Postoc in the Escobar Lab, has been named one of ten 2022 Pew Latin American Fellows in the Biomedical Sciences. Read More

Potential Seen for Tailoring Acute Myeloid Leukemia Treatment

December 3, 2018 | Categories: Announcements, Research | Tagged: , ,

Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML). Research on the drug responses of leukemia stem cells may reveal why some […] Read More

Study: Using big data to help fight a deadly cancer

January 12, 2018 | Categories: Research | Tagged: , ,

Researchers built an algorithm to discern which drugs might best combat patients’ individual cases of acute myeloid leukemia. The statistics are grim. For patients fighting an aggressive form of leukemia known as acute myeloid leukemia, or AML, doctors over the last 40 years have usually used a combination of two drugs to fight the disease, but it seldom cures it. Read More